Search

everythinglearnresearchcommunity

for

Search:↓

Certain skin rashes can indicate COVID-19 severity, with chilblains-like rashes linked to milder cases and livedoid patterns to more severe cases.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Anti-androgens might help reduce COVID-19 severity in men.

Nitric oxide may help treat COVID-19 pneumonia by fighting the virus and easing symptoms.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Cepharanthine shows promise as a COVID-19 treatment.

Cepharanthine may help treat COVID-19 by targeting multiple pathways.

Antiandrogens don't help with COVID-19 and aren't recommended.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

Gender and social factors, not just biology, affect COVID-19 death rates.

Natural products might help treat COVID-19, but current drugs like hydroxychloroquine haven't worked.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Training programs are needed to improve home COVID-19 management in Mangalore.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

Females have stronger immune responses to COVID-19 than males, leading to better outcomes.

Higher variability in systolic blood pressure increases long-term mortality risk in coronary artery disease patients.

iPSCs are promising for studying and treating COVID-19.

A standardized drug development platform is essential for efficient and effective drug repurposing, especially during pandemics.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

Training programs are needed to improve home COVID-19 management practices.

More skin issues appeared in the emergency department during COVID-19, highlighting the need for better dermatology training and resources.

Training programs are needed to improve home COVID-19 management and educate on vital sign monitoring and danger signs.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Reprogramming macrophages to resolve inflammation can help reduce severe COVID-19 complications.